Impact of Treatment With ALVEOGYL in Patients With Post-extraction Dry Socket
Prospective, Multicentre Clinical Trial Measuring the Impact of Treatment With ALVEOGYL in Patients With Post-extraction Dry Socket
3 other identifiers
observational
120
2 countries
16
Brief Summary
Alveogyl (Septodont, Saint-Maur-des-Fossés - France) is a Medical Device used as dressing in case of dry socket. ALVE study is a clinical investigation measuring Alveogyl performance and safety in patients with post-extraction dry socket. The study takes place in India and in France where Alveogyl is already marketed, since 2010 in France and since 2014 in India .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2022
Typical duration for all trials
16 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 7, 2022
CompletedFirst Posted
Study publicly available on registry
September 10, 2022
CompletedStudy Start
First participant enrolled
December 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 26, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 26, 2025
CompletedResults Posted
Study results publicly available
February 9, 2026
CompletedMarch 2, 2026
February 1, 2026
2.5 years
September 7, 2022
January 21, 2026
February 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Using a Visual Analog Scale (VAS : 0-10)
Patients with no pain or mild pain at Day7 The pain is measured by patients in a diary using a Visual Analogue Scale (VAS: 0-10 mm; 0 no pain - 10 maximum pain) 7 days after treatment with Alveogyl.
7 days post-treatment
Secondary Outcomes (6)
Analgesic Use
3 and 5 days post-treatment
Healing of the Alveolar Mucosa
7 days post-treatment
Signs of Local Inflammation
7 days post-treatment
Antiseptic Effect
7 days post-treatment
Hemostasis
Immediately after Alveogyl placement and Day 7 after treatment
- +1 more secondary outcomes
Study Arms (1)
Study population
Study patients are patients with post-extraction dry socket.
Interventions
The patients will be treated by Alveogyl. Global treatment protocol (curettage, cleaning, local anaesthesia etc.) of the dry socket is at the discretion of the Investigator. Alveogyl is used as an alveolar dressing. Placement of Alveogyl (about 0.2 g of paste) into the dental socket is done according to its instruction for use by a dental professional only.
Eligibility Criteria
Patients with a dry socket occuring after the extraction of a permanent tooth (mature or immature).
You may qualify if:
- Male or female patient, adult or child
- Positive diagnosis of dry socket occurring after the extraction of a permanent tooth (mature or immature)
- Signed informed consent
- In France only :Patient affiliated to a Health Insurance Scheme ("sécurité sociale")
You may not qualify if:
- Spreading infection in the alveolar socket
- Placement of Alveogyl done immediately after tooth extraction
- Multiple post-extraction dry sockets
- Patient treated with cervico-facial radiotherapy
- Immunodeficiency related to any diseases or current treatments
- Psychiatric patient or patient unable to assess his/her pain via the study Pain VAS
- Patient with history of hypersensitivity to one of the components
- Patient on post extraction of deciduous teeth
- Participation in another clinical investigation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Septodontlead
- SMO Clinical Researchcollaborator
- QualityStatcollaborator
Study Sites (16)
Hospital Henri-Mondor (AP-HP)
Créteil, 94000, France
Odontology Department - Pitié-Salpêtrière Hospital
Paris, 75013, France
Mallige Hospital
Bangalore, Karnataka, 560001, India
Smile Dental Care
Bangalore, Karnataka, 560024, India
Perfect Dental Studio
Bangalore, Karnataka, 560076, India
Cavalier Hospital
Bangalore, Karnataka, 56009443, India
Smile Dental Clinic
Bangalore, Karnataka, 560094, India
The Dental Avenues
Bangalore, Karnataka, 560098, India
Sri Dental Multispeciality Dental Hospital
Hyderabad, 500070, India
Vrisa Dental
Hyderabad, 500079, India
Eledent International Digital Dentistry
Hyderabad, 500085, India
Vardhaman Dental Care
Mumbai, 421203, India
Mayur Dental Clinic
Mumbai, 421501, India
Smile Gallery Dental Care Center
Pune, 411004, India
Dr. Salke Dental & Implant Centre
Pune, 411016, India
Sri Siddhartha Dental College
Tumakuru, 572107, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Farid BENABDALLAH
- Organization
- Septodont
Study Officials
- STUDY DIRECTOR
Géraldine Lescaille, DDS, PhD
Odontology department - Pitié-Salpêtrière Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 7, 2022
First Posted
September 10, 2022
Study Start
December 13, 2022
Primary Completion
June 26, 2025
Study Completion
June 26, 2025
Last Updated
March 2, 2026
Results First Posted
February 9, 2026
Record last verified: 2026-02